Rhode Island S2889 prohibits testosterone prescriptions from being transmitted or reported in the state's prescription drug monitoring database and.
Rhode Island S2889 amends the Uniform Controlled Substances Act to ensure that prescriptions for testosterone are not transmitted or reported within the state's prescription drug monitoring database. The act also mandates the removal of all existing information concerning prior testosterone prescriptions from the database. This change aims to protect patient privacy and confidentiality regarding testosterone prescriptions. The act takes effect upon passage.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.